Chief of VA Research Departs amidst allegations of misconduct, financial indiscretion – BNA Sat, 13 Dec 2003 The Bureau of National Affairs (BNA) reports that Dr. Nelda Wray, chief of research at the Veterans Affairs, “leaves office as the VA Inspector General prepares to release results of an investigation into…
How to earn promotions in pharmaceutical industry Tue, 6 Sep 2005 In the world of pharmaceuticals, careers are made by marketing the worst products that cause the greatest harm. Contact: Vera Hassner Sharav 212-595-8974 XenoPort Appoints Gary D. Tollefson, Former Lilly Executive, to Board Company Snapshot: XNPThttp://www.xenoport.com SANTA CLARA, Calif.,…
FDA’s Lethal Weakness Requires More than Committees Sun, 7 Nov 2004 Bloomberg News reports that New York State Attorney General Eliot Spitzer requested information from Pfizer about the promotion of some of its drugs for unapproved uses – the recalled diabetes drug, Rezulin and the antidepressant, Zoloft were named. In…
Not-So-Public-Relations: Drug Industry & Bioethics – is it casuistry or sophistry? Fri, 19 Dec 2003 Carl Elliott is a clear eyed academic who teaches bioethics at the University of Minnesota . He is currently a visiting associate professor at School of Social Sciences at the Institute for Advanced Study at Princeton….
AHRP InfoMail Return to Home Page Return to InfoMail Media Coverage List MediaCoverage News Stories on Human ResearchProtection andCommentary by Vera Hassner Sharav February 19a, 2002 INSANE PSYCHIATRY: AProfession Run Amok FYI Nicholas Regush is an award winning reporter on medicaland scientific issues. For 6 years he was the medical…
NY Times Does it Again – Drug Advertisers Get Front Page Coverage to Boost SSRI Market Wed, 2 Jun 2004 The New York Times saw fit to print a report about preliminary, unpublished findings of a study whose authors claim to have “found that Prozac helps teenagers overcome depression far…
4 compelling reasons against Mental Health Parity Fri, 12 Sep 2003 Compelling reasons NOT to approve insurance parity for mental health services come from the following recent reports suggesting that mental health services and treatments have often done more damage than good. Until psychiatry and mental health service providers develop…
Lilly's aggressive marketing of Xigris does indeed epitomize the worst ofthis industry's mission.
"UK regulators did not receive findings that might have warned them of damage TGN1412 could do."
A Special Article By Curt D. Furberg, MD, PhD; Arthur A. Levin, MPH; Peter A. Gross, MD; Robyn S. Shapiro, JD; Brian L. Strom, MD, MPH
“The Drug Trial That Went Wrong” is an investigative report by Chanel 4 (UK) about the circumstances surrounding the near fatal drug trial testing the safety of TGN1412, a monoclonal antibody drug, conducted in March 2006 at London’s Northwick Park Hospital. [1] http://news.bbc.co.uk/go/pr/fr/-/1/hi/health/5377226.stm It airs momorrow.
Evidence of an association between violence and widely prescribed antidepressant drugs is the focus of this Infomail.
